http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19990022301-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-181 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-18 |
| filingDate | 1997-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1999-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-19990022301-A |
| titleOfInvention | Physiologically active substance II-2128-1 |
| abstract | The present invention relates to a novel compound EI-2128-1 having an inhibitory effect on the production of IL-1, represented by the formulan n n [Formula I] |
| priorityDate | 1996-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.